Evicenter
MarkdownMedical informationP&T meetings
Onvuzosiran (ADX-324)

Prophylaxis of hereditary angioedema attacks

Launch
Not announced
Last updated
119 sources

Product information and disease descriptionProduct description

Phase of product development

9 evidence topics · 11 sources

Launch

No evidence found.

Regulatory designations outside the United States

No evidence found.